PapersPMID:37343496
Astaxanthin inhibits oxidative stress and apoptosis in diabetic retinopathy.
What moved
1 findingHow to read these marks →- Inhibits KEAP1
insufficient
“Additionally, ASX could inhibit the expression of Keap1, promote the transport of Nrf2 from cytoplasm to nucleus and facilitate the expressions of HO-1, NQO1, γ-glutamylcysteine synthetase, (γ-GCS) and GPx.”
- Study
- animal · not in humans
- Duration
- 6 weeks
- Dose studied
- 20 mg/kg for 45 days
- Population
- streptozotocin-induced diabetic retinopathy rats, retinal tissue
Study record
- Design
- animal study, in vivo
- Species
- animal
- Population
- streptozotocin-induced diabetic retinopathy rats
- Participants
- not reported
- Comparator
- not stated in the paper
- Duration
- 45 days
- Endpoints measured
- 7
astaxanthin